CD274 and neoplasm: Indeed, immune evasion by the tumor is enhanced by overexpression of the immune checkpoint molecule programmed-death-ligand-1 (PD-L1) on tumor cells and/or tumor-infiltrating immune cells, which is found in around 55% of HNSCC patients and especially after prolonged presence of the tumor.